Evidence has been reported for the presence of modified FN in atherosclerotic lesions and heart failure (14, 19) and for a role for excess FN in the development of multiple diseases including atherosclerosis and fibrosis in multiple organs (17, 19, 44, 45, 46). This evidence concerns the gene FN1 and heart failure.